Navigation Links
Ceelox Provides Biometric Identity Access to Cloud Applications
Date:4/13/2011

TAMPA, Fla., April 13, 2011 /PRNewswire/ -- Ceelox, Inc. (OTCBB: CELO) announced today that the company has created a solution for secure login to cloud applications using biometrics. Ceelox ID Online® utilizes a fingerprint authentication and the OpenID protocol to provide an Internet server-based biometric software application. This enables users to securely authenticate without the threat of having their credentials, i.e. user name and password, compromised or stolen by eliminating the feasibility of any replay attack. Once Ceelox ID Online® grants access, the OpenID protocol is used to create a "relying party" relationship that can be locked-down with any cloud application providing the highest level of secure authentication available.

Today, user name and password is the most common login method used to gain access to cloud applications. Ceelox has begun promoting the use of Ceelox ID Online® to a variety of companies who are developing cloud platforms for enterprise and consumer use. These cloud applications include CRM, secure data storage, email encryption, etc. Likewise, Ceelox ID Online® may be used to biometrically login a person to a social website such as Facebook. The significant advantage that Ceelox ID Online® offers is the ability to validate a person is who they claim to be and not an imposter who has used stolen credentials, such as user name and password, digital certificate, or token, to log into another person's account.

By design, OpenID was created to maximize convenience and security for all Internet and cloud users by allowing them to keep a single set of credentials that will log them into all services. With Ceelox ID Online®, Ceelox has expanded the power of the OpenID protocol by eliminating the fear of having a password or other access credential stolen. Instead, biometrics is used to authenticate a person and, as a result, a user doesn't need to worry about an unscrupulous or insecure web
'/>"/>

SOURCE Ceelox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Ceelox Offers Beta Release of Ceelox ID 7 for Personal Computers
2. Study provides new way to classify E. coli bacteria and test for fecal contamination
3. New information provides sustainable options for greenhouse operations
4. SDSCs CIPRES Gateway provides window to the past -- and fast
5. New book on animal behavior provides integrated view
6. New imaging technique provides rapid, high-definition chemistry
7. Study provides new tool to monitor coral reef vital signs
8. Study provides explanation for connection between low birth weight and obesity later in life
9. University of Missouri researcher study provides insight into how corn makes hormones
10. Chicken litter provides organic alternative to synthetic fertilizers
11. 2 in 1: Multi-tasking protein provides new approaches for anti-tuberculosis drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... VEGAS , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ...
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ...  report to their offering. One major ... With continuous advances in technology, it is important to ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... The Wildlife Conservation Society tracked a southern elephant seal ... York to Sydney and back again. , WCS tracked the ... animal nicknamed Jackson was tagged on the beach ... WCS conservationists fitted Jackson with a small satellite transmitter that ...
... Therapeutics, Inc. announced today promising clinical results ... umbilical cord blood) as part of double-umbilical cord ... malignancies who have undergone reduced-intensity conditioning therapy.  The ... American Society of Hematology (ASH) meeting, being held ...
... of Toronto have found an explanation for how the ... system to prevent infection, offering a potential clue to ... multiple sclerosis. "The findings shed light on the ... gut," said Prof. Jennifer Gommerman, an Associate Professor in ...
Cached Biology News:Elephant seal travels 18,000 miles 2Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference 2Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference 3Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference 4Intestine crucial to function of immune cells, research shows 2Intestine crucial to function of immune cells, research shows 3
(Date:1/22/2015)... Geneva, Switzerland (PRWEB) January 22, 2015 ... for characterized mammalian Research Cell Banks (RCBs) used for ... generated Research Cell Banks will include Next-Generation Sequencing ... cell’s genetic architecture de-risks biologic manufacturing by ensuring the ...
(Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, Inc., ... Inc. (NASDAQ: SQNM ), the leading ... for next generation noninvasive prenatal tests (NIPT). Through ... technology, called Mantis™, to advance analysis of clinically-relevant ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. ... company focused on advanced wound care, announces that ... tissues, have been added to the Premier, Inc. ... the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product ...
(Date:12/24/2014)... DALLAS and NEW YORK , ... a biopharmaceutical company advancing patient care in critical areas, announced ... of common stock, and warrants to purchase up to an ... of $4.00 per share and $.01 per warrant.  The warrants ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... NEW BRUNSWICK, N.J., Jan. 4, 2012 The HealthCare Institute ... 2011 economic impact survey, which indicates that the life sciences ... economy. For the eighth consecutive year, the study was conducted ... slowing of economic activity, it is important to note that ...
... Calif., Jan. 4, 2012  Telik, Inc. (Nasdaq: TELK) today ... a corporate update at the 5th Annual OneMedForum Conference ... (3:00 p.m. Eastern time) in San Francisco.  A live ... on the Telik website, www.telik.com .  The archived ...
... InterMune, Inc. (NASDAQ: ITMN) today announced that it will ... of Esbriet® (pirfenidone) in Germany, as well as other ... open of the U.S. markets on Thursday, January 5, ... hosted by InterMune at 8:30 a.m. Eastern time that ...
Cached Biology Technology:HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data 2HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data 3InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5 2
Request Info...
Detect and measure levels of mouse IgG2b antibody isotypes quickly and easily....
Competitors to lower non-specific signal...
... FITC is used as the ... tissues or culture cells where the ... It is highly recommended that proper ... primary antibody, be included in experiments ...
Biology Products: